Thu.Sep 23, 2021

article thumbnail

The hypocrisy of big pharma

World of DTC Marketing

SUMMARY: Pfizer will earn over 26 billion dollars from their COVID vaccine, while Moderna and J&J also look to their vaccines for more profit dollars. The suggestion by Pfizer’s CEO that drug pricing negotiations with the government would slow innovation is PR doubletalk. Recently Pfizer’s CEO sent a video message to company employees urging them to fight proposed government drug price negotiations and expressing frustration with Congress, considering using the projected savings

Pharma 214
article thumbnail

Podcast: Simple ways you can become a better persuasive communicator

Authentic Influence Group

I’m excited to share a podcast I recently had the opportunity to be part of. I sat down with Patrick Kothe of Mastering Medical Device to discuss simple ways you can become a better persuasive communicator. Here’s a snippet: So there are a number of factors that are involved in persuasive communication. First, you have to start with a foundation of really building trust with someone, because if I'm trying to communicate to you and persuade you to take on my project, or to give me more budget, if

Medical 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

A Roadmap For Value Based Selling

Integrity Solutions

A value based selling approach is intended to help salespeople focus their client conversations around creating product value versus price. This helps to better differentiate themselves in a highly competitive market. Yet, for all the buzz surrounding solution or value selling, many organizations still struggle to execute on it. What’s holding them back?

article thumbnail

Equitable Evaluations for a Hybrid Workforce: An Intro for Leaders

ALULA

Through all the changes that the pandemic has imposed on the corporate world, critical aspects of the business can fall by the wayside. Performance evaluations are one such aspect, and in these uncertain times, keeping those evaluations fair and equitable is of utmost importance.

52
article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud